PSMB9 and cancer: However, in uterine rhabdomyosarcoma, LMP2/β1i-positive cells were clearly observed.<h4>Conclusion</h4>It is expected that establishing a diagnostic and treatment method targeting characteristics of mesenchymal tumor cells will lead to the treatment of malignant tumors with a low risk of recurrence and metastasis.